Reversible room-temperature ionic liquids

US9433895B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9433895-B2
Application numberUS-201314072439-A
CountryUS
Kind codeB2
Filing dateNov 5, 2013
Priority dateJan 29, 2007
Publication dateSep 6, 2016
Grant dateSep 6, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

One aspect of the present invention relates to salts that are room-temperature ionic liquids (RTILs), methods of making them, and methods of using them in connection with temporary or permanent gas sequestration. Another aspect of the present invention relates to a class of solvents which can be transformed into RTILs by exposure to a gas, and methods of using them in connection with temporary or permanent gas sequestration.

First claim

Opening claim text (preview).

We claim: 1. A salt represented by: wherein R 9 is absent or represents one or more substituents attached to the ring, each of which is independently selected from the group consisting of H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —OR 8 , —N(R 8 ) 2 , —SR 8 , —C(═O)OR 8 , —OC(═O)R 8 , —NR 8 C(═O)R 8 , —C(═O)N(R 8 ) 2 , —C(═O)SR 8 , —SC(═O)R 8 , —S(═O)R 8 , —S(═O) 2 R 8 , —S(═O) 2 OR 8 , —C(═O)R 8 , —C(═NR 8 )R 8 , —C(═S)R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , —C(R 8 ) 3 , and —(CH 2 ) n —NH 2 ; z is zero or an integer in the range of 1 to 3; R 5 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —OR 8 , —N(R 8 ) 2 , —SR 8 , —C(═O)OR 8 , —OC(═O)R 8 , —NR 8 C(═O)R 8 , —C(═O)N(R 8 ) 2 , —C(═O)SR 8 , —SC(═O)R 8 , —S(═O)R 8 , —S(═O) 2 R 8 , —S(═O) 2 OR 8 , —C(═O)R 8 , —C(═NR 8 )R 8 , —C(═S)R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , —C(R 8 ) 3 , or —(CH 2 ) n —NH 2 ; R 6 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —OR 8 , —N(R 8 ) 2 , —SR 8 , —C(═O)OR 8 , —OC(═O)R 8 , —NR 8 C(═O)R 8 , —C(═O)N(R 8 ) 2 , —C(═O)SR 8 , —SC(═O)R 8 , —S(═O)R 8 , —S(═O) 2 R 8 , —S(═O) 2 OR 8 , —C(═O)R 8 , —C(═NR 8 )R 8 , —C(═S)R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡R 8 , —CH(R 8 ) 2 , —C(R 8 ) 3 , or —(CH 2 ) n —NH 2 ; Y represents independently for each occurrence O or S; R 8 represents independently for each occurrence —(CH 2 ) n —CH 3 , cycloalkyl, aryl, or heteroaryl; and n represents independently for each occurrence an integer in the range 1-10 inclusive. 2. The salt of claim 1 , wherein R 9 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; R 5 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; and R 6 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 . 3. The salt of claim 1 , wherein R 9 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; R 5 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; and R 6 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 . 4. The salt of claim 1 , wherein R 9 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; R 5 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; R 6 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; and Y is O. 5. A salt represented by: wherein R 5 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —OR 8 , —N(R 8 ) 2 , —SR 8 , —C(═O)OR 8 , —OC(═O)R 8 , —NR 8 C(═O)R 8 , —C(═O)N(R 8 ) 2 , —C(═O)SR 8 , —S C(═O)R 8 , —S(═O)R 8 , —S(═O) 2 R 8 , —S(═O) 2 OR 8 , —C(═O)R 8 , —C(═NR 8 )R 8 , —C(═S)R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , —C(R 8 ) 3 , or —(CH 2 ) n —NH 2 ; R 6 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —OR 8 , —N(R 8 ) 2 , —SR 8 , —C(═O)OR 8 , —OC(═O)R 8 , —NR 8 C(═O)R 8 , —C(═O)N(R 8 ) 2 , —C(═O)SR 8 , —S C(═O)R 8 , —S(═O)R 8 , —S(═O) 2 R 8 , —S(═O) 2 OR 8 , —C(═O)R 8 , —C(═NR 8 )R 8 , —C(═S)R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , —C(R 8 ) 3 , or —(CH 2 ) n —NH 2 ; Y represents independently for each occurrence O or S; R 8 represents independently for each occurrence —(CH 2 ) n —CH 3 , cycloalkyl, aryl, or heteroaryl; and n represents independently for each occurrence an integer in the range 1-10 inclusive. 6. The salt of claim 5 , wherein R 5 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; and R 6 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 . 7. The salt of claim 5 , wherein R 5 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; and R 6 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 . 8. The salt of claim 5 , wherein R 5 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; R 6 represents H, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, —(CH 2 ) n —R 8 , —CH(R 8 ) 2 , or —C(R 8 ) 3 ; and Y is O. 9. A method of preparing a salt, comprising the step of contacting a gas with a first compound and a second compound, wherein said first compound is represented by wherein R 9 is absent or represents one or more substituents attached to the ring, each of which is independently selected from the group consisting of H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —OR 8 , —N(R 8 ) 2 , —SR 8 , —C(═O)OR 8 , —OC(═O)R 8 , —NR 8 C(═O)R 8 , —C(═O)N(R 8 ) 2 , —C(═O)SR 8 , —S C(═O)R 8 , —S(═O)R 8 , —S(═O) 2 R 8 , —S(═O) 2 OR 8 , —C(═O)R 8 , —C(═NR 8 )R 8 , —C(═S)R 8 , —C(R 8 )═C(R 8 ) 2 , —C≡CR 8 , —CH(R 8 ) 2 , —C(R 8 ) 3 , and —(CH 2 ) n —NH 2 ; R 8 represents independently for each occurrence —(CH 2 ) n —CH 3 , cycloalkyl, aryl, or heteroaryl; n represents independently for each occurrence an integer in the range 1-10 inclusive; z is zero or an integer in the range of 1 to 3; and said second compound is represented by wherein R 5 represents H, halogen, alkyl, fluoroalkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —(CH 2 ) n —R 8 , —OR 8 , —N(R 8 ) 2 , —SR 8 , —C(═O)OR 8 , —OC(═O)R 8 , —NR 8 C(═O)R 8 , —C(═O)N(R 8 ) 2 , —C(═O)SR 8 , —S C(═O)R 8 , —S(═O)R 8 , —S(═O) 2 R 8 , —S(═O) 2 OR 8 , —C(═O)R 8 , —C(═NR 8 )

Assignees

Inventors

Classifications

  • Ortho-condensed systems · CPC title

  • having carbon atoms of amidino groups bound to acyclic carbon atoms · CPC title

  • Selection of liquid materials for use as absorbents · CPC title

  • by reactions not involving the formation of sulfide groups · CPC title

  • Carbamic acids; Salts of carbamic acids (unsubstituted carbamic acid or salts thereof C01B21/12) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9433895B2 cover?
One aspect of the present invention relates to salts that are room-temperature ionic liquids (RTILs), methods of making them, and methods of using them in connection with temporary or permanent gas sequestration. Another aspect of the present invention relates to a class of solvents which can be transformed into RTILs by exposure to a gas, and methods of using them in connection with temporary …
Who is the assignee on this patent?
Univ Georgetown
What technology area does this patent fall under?
Primary CPC classification B01D53/1493. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).